These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 19803946)
21. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Kommoss F; Oliva E; Bhan AK; Young RH; Scully RE Mod Pathol; 1998 Jul; 11(7):656-64. PubMed ID: 9688187 [TBL] [Abstract][Full Text] [Related]
22. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B. Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251 [TBL] [Abstract][Full Text] [Related]
23. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences. Ciriş M; Erhan Y; Zekioglu O; Bayramoglu H Acta Obstet Gynecol Scand; 2004 May; 83(5):491-6. PubMed ID: 15059165 [TBL] [Abstract][Full Text] [Related]
24. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Boggess JF; Soules MR; Goff BA; Greer BE; Cain JM; Tamimi HK Gynecol Oncol; 1997 Jan; 64(1):64-9. PubMed ID: 8995549 [TBL] [Abstract][Full Text] [Related]
26. Clinical factors and biomarkers in ovarian tumors development. Vrabie CD; Petrescu A; Waller M; Dina I Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637 [TBL] [Abstract][Full Text] [Related]
27. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients]. Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence. Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856 [TBL] [Abstract][Full Text] [Related]
29. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Mom CH; Engelen MJ; Willemse PH; Gietema JA; ten Hoor KA; de Vries EG; van der Zee AG Gynecol Oncol; 2007 May; 105(2):365-72. PubMed ID: 17306349 [TBL] [Abstract][Full Text] [Related]
30. [The values of urine cysteine protein activity in the diagnosis of ovarian cancer]. Xi MR; Peng ZL; Cao ZY Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):85-7, 123. PubMed ID: 8033632 [TBL] [Abstract][Full Text] [Related]
31. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682 [TBL] [Abstract][Full Text] [Related]
32. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
33. Secondary amenorrhea with low serum luteinizing hormone and follicle-stimulating hormone caused by an inhibin A- and inhibin B-producing granulosa cell tumor. Agha-Hosseini M; Aleyaseen A; Safdarian L; Kashani L Taiwan J Obstet Gynecol; 2009 Mar; 48(1):72-5. PubMed ID: 19346197 [TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Zhao C; Bratthauer GL; Barner R; Vang R Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194 [TBL] [Abstract][Full Text] [Related]
36. Validation of serum biomarkers for detection of early-stage ovarian cancer. Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648 [TBL] [Abstract][Full Text] [Related]
37. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277 [TBL] [Abstract][Full Text] [Related]
38. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA. Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832 [TBL] [Abstract][Full Text] [Related]
39. Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival. Engqvist H; Parris TZ; Rönnerman EW; Söderberg EMV; Biermann J; Mateoiu C; Sundfeldt K; Kovács A; Karlsson P; Helou K Oncotarget; 2018 Oct; 9(80):35162-35180. PubMed ID: 30416686 [TBL] [Abstract][Full Text] [Related]